These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28151845)

  • 21. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
    McAuley J; Boyer KM; Patel D; Mets M; Swisher C; Roizen N; Wolters C; Stein L; Stein M; Schey W
    Clin Infect Dis; 1994 Jan; 18(1):38-72. PubMed ID: 8054436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
    Petersen E; Schmidt DR
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):175-82. PubMed ID: 15482110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular manifestations in congenital toxoplasmosis.
    Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
    Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
    N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
    Wirden M; Botterel F; Romand S; Ithier G; Bourée P
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of a case of severe congenital toxoplasmosis].
    Pujol-Riqué M; Gómez-López L; Tudó G; Falgueras T; Costa J; Rodríguez-Miguélez JM; Coll O; Valls ME
    Med Clin (Barc); 1999 Nov; 113(18):701-3. PubMed ID: 10650573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
    Gras L; Gilbert RE; Ades AE; Dunn DT
    Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
    Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
    J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
    Lipka B; Milewska-Bobula B; Filipek M
    Wiad Parazytol; 2011; 57(2):87-92. PubMed ID: 21682092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
    Maisonneuve H; Faber C; Piens MA; Garin JP
    Presse Med; 1984 Mar; 13(14):859-62. PubMed ID: 6231609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?].
    Genuini M; Freihuber C; Girard I; de Montgolfier I; Kieffer F; Mitanchez D
    Arch Pediatr; 2011 Oct; 18(10):1084-6. PubMed ID: 21885264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
    Chêne G; Thiébaut R
    Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):299-304. PubMed ID: 19430657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital toxoplasmosis in the state of Minas Gerais, Brazil: a neglected infectious disease?
    Carellos EV; Caiaffa WT; Andrade GM; Abreu MN; Januário JN;
    Epidemiol Infect; 2014 Mar; 142(3):644-55. PubMed ID: 23823156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow].
    Weissbach G
    Z Arztl Fortbild (Jena); 1965 Jan; 59(1):10-22. PubMed ID: 5885819
    [No Abstract]   [Full Text] [Related]  

  • 35. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
    Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C
    Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
    Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
    Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital toxoplasmosis in a neonate with significant neurologic manifestations.
    Chuang YC; Chen JY; Ji DD; Su PH
    J Formos Med Assoc; 2012 Apr; 111(4):232-3. PubMed ID: 22526213
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.
    Ben-Harari RR; Goodwin E; Casoy J
    Drugs R D; 2017 Dec; 17(4):523-544. PubMed ID: 28879584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxoplasmosis in pregnancy and its transmission to the fetus.
    Desmonts G; Couvreur J
    Bull N Y Acad Med; 1974 Feb; 50(2):146-59. PubMed ID: 4521728
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of congenital toxoplasmosis.
    Wilson CB
    Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.